Data sheet

Benchling for antibody therapeutics R&D

Antibodies are an important class of therapeutic agents which have evolved significantly over the past 30 years. Antibody R&D is now more streamlined than ever, but several factors continue to contribute to its complexity.
This data sheet discusses:
  • The complexities faced during both research and discovery phases 

  • Why current solutions fail to meet these needs

  • How Benchling’s capabilities have helped address these challenges for leading antibody companies

Companies using Benchling

View data sheet

Join over 200,000 scientists using Benchling to power their biotech R&D

Helix Image